Novartis AG

Open: 99.85 Close: 99.37 Change: -0.48

5 risks of investing in Novartis AG found by an AI after reading the whole internet.

The game is changing. There is a new strategy to evaluate Novartis AG fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: AG, Novartis, ADR, drug, price, value, month, …

Concept Map

Semantic Network

Stock Summary

Novartis AG researches, develops, manufactures, markets, markets healthcare products. The company operates through two segments: Innovative Medicines and Sandoz. Novarti has a license and collaboration agreement with Alnylam Pharmaceuticals.

Today's Summary

Novartis AG ADR share price volatility has ranged in value from as little as $71.0039 up to $105.56 in the last 12 months. MUFG Securities EMEA plc opened a new position in the company during Q4 2022 valued at approximately $55.1 million.

Today's News

Novartis AG ADR is a drug manufacturers-general business based in the US. It employs 103,000 staff and has a trailing 12-month revenue of $52.2 billion. Novartis AG ADR share price volatility has ranged in value from as little as $71.0039 up to $105.56 in the last 12 months. The market (NYSE average) beta is 1, while Novartes AG ADRs is 0.4727. Investors Bullish on Novartis AG (NYSE:NVS) Despite Sell Ratings from Analysts. MUFG Securities EMEA plc opened a new position in the company during Q4 2022 valued at approximately $55.1 million. Novartis AG (NVS) stock is trading at $97.02 as of 1:04 PM on Thursday, Jun 1, an increase of $0.77, or 0.8% from the previous closing price of $96.25. The company was a leading decliner within the drugs industry, falling 64 cents (-1.1%) to $59.39. Agilent Technologies vs Novartis AG: Which is a Better Buy? AI Stock Analysis Start now and save 50% for the first 3 months Ticker Company Your search.

Stock Profile

"Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland."

Keywords

How much time have you spent trying to decide whether investing in Novartis AG? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Novartis AG are: AG, Novartis, ADR, drug, price, value, month, and the most common words in the summary are: novartis, market, stock, ag, job, disease, zacks, . One of the sentences in the summary was: Novartis AG ADR share price volatility has ranged in value from as little as $71.0039 up to $105.56 in the last 12 months. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #novartis #market #stock #ag #job #disease #zacks.